Delays for diagnosis and treatment of lung cancers: A systematic review

Clinical Respiratory Journal

Volumn 10, Issue 3, 2016, Pages 267-271

  Vinas, Florent ^a   Ben Hassen, Ikram ^a   Jabot, Laurence ^a   Monnet, Isabelle ^a   Chouaid, Christos ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Delays; Diagnosis; Health system; Lung cancer; Organizations

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

CANCER PROGNOSIS; CANCER SURVIVAL; COMORBIDITY; DELAYED DIAGNOSIS; GENE MUTATION; HEALTH CARE QUALITY; HUMAN; NON SMALL CELL LUNG CANCER; ONCOGENE; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; REVIEW; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; THERAPY DELAY; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE MANAGEMENT; FEMALE; LUNG NEOPLASMS; MALE; PROGNOSIS; TIME TO TREATMENT;

CARCINOMA, NON-SMALL-CELL LUNG; DELAYED DIAGNOSIS; DISEASE MANAGEMENT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROGNOSIS; TIME-TO-TREATMENT;

EID: 84962706472     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12217     Document Type: Review

References (24)

1. Valdés S, García E, Pérez H, Hernández M. Length of diagnostic delay in patients with non-small-cell lung cancer. MEDICC Rev. 2010;12: 29-32.
2. Diaconescu R, Lafond C, Whittom R. Treatment delays in non-small cell lung cancer and their prognostic implications. J Thorac Oncol. 2011;6: 1254-1259.
3. Myrdal G, Lambe M, Hillerdal G, Lamberg K, Agustsson T, Ståhle E. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax. 2004;59: 45-49.
4. Salomaa ER, Sällinen S, Hiekkanen H, Liippo K. Delays in the diagnosis and treatment of lung cancer. Chest. 2005;128: 2282-2288.
5. Virally J, Choudat L, Chebbo M, etal. Epidemiologie et délais de prise en charge de 355 patients avec cancer du poumon. Rev Mal Respir. 2006;23: 43-48.
6. INCA. Du diagnostic au premier traitement: délais de prise en charge des cancers enregistrés par les registres spécialisés du réseau Francim 1999-2008. Boulogne-Billancourt, 2012.
7. Deegan PC, Heath L, Brunskill J, Kinnear WJ, Morgan SA, Johnston ID. Reducing waiting times in lung cancer. J R Coll Physicians Lond. 1998;32: 339-343.
8. Gould M, Ghaus S, Olsson J, Schultz E. Timeliness of care in veterans with non-small cell lung cancer. Chest. 2008;133: 1167-7.
9. Berthelet E, Truong PT, Lesperance M, Lim JT, Wai ES, MacNeil MV, Liu M, Joe H, Olivotto IA. Examining ime intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer. Am J Clin Oncol. 2006;29: 21-26.
10. González-Barcala FJ, García-Prim JM, Álvarez-Dobaño JM, Moldes-Rodríguez M, García-Sanz MT, Pose-Reino A, Valdés-Cuadrado L. Effect of delays on survival in patients with lung cancer. Clin Transl Oncol. 2010;12: 836-842.
11. Skaug K, Eide GE, Gulsvik A. Predictors of long-term survival of lung cancer patients in a Norwegian community. Clin Respir J. 2011;5: 50-58.
12. Chandra S, Mohan A, Guleria R, Singh V, Yadav P. Delays during the diagnostic evaluation and treatment of lung cancer. Asian Pac J Cancer Prev. 2009;10: 453-456.
13. Yaman N, Ozgen A, Celik P, Ozyurt BC, Nese N, Coskun AS, Yorgancioglu A. Factors affecting the interval from diagnosis to treatment in patients with lung cancer. Tumori. 2009;95: 702-705.
14. Quarterman RL, McMillan A, Ratcliffe MB, Block MI. Effect of preoperative delay on prognosis for patients with early stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;125: 108-113.
15. Yorio JT, Xie Y, Yan J, Gerber DE. Lung cancer diagnostic and treatment intervals in the United States: a health care disparity? J Thoracic Oncol. 2009;4: 1322-1330.
16. Giroux Leprieur E, Labrune S, Giraud V, Gendry T, Cobarzan D, Chinet T. Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer. Clin Lung Cancer. 2012;13: 363-368.
17. British Thoracic Society. BTS recommendations to respiratory physicians for organizing the care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. Thorax. 1998;53: S1-8.
18. Department of Health. The NHS cancer plan. London: Department of Health, 2000. Measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000. Can J Surg. 2005;48: 137-142.
19. Lo DS, Zeldin RA, Skrastins R, etal. Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis. J Thorac Oncol. 2007;2: 1001-1006.
20. Hunnibell LS, Rose MG, Connery DM, Grens CE, Hampel JM, Rosa M, Vogel DC. Using nurse navigation to improve timeliness of lung cancer care at a veterans hospital. Clin J Oncol Nurs. 2012;16: 29-36.
21. Brocken P, Kiers BA, Looijen-Salamon MG, Dekhuijzen PN, Smits-van der Graaf C, Peters-Bax L, de Geus-Oei LF, van der Heijden HF. Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning. Lung Cancer. 2012;75: 336-341.
22. Lindeman NI, Cagle PT, Beasley MB, etal. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Thorac Oncol. 2013;8: 823-859.
23. Devbhandari MP, Bittar MN, Quennell P, etal. Are we achieving the current waiting time targets in lung cancer treatment? Result of a prospective study from a large United Kingdom teaching hospital. J Thorac Oncol. 2007;2: 590-592.
24. Macià F, Pumarega J, Gallén M, Porta M. Time from (clinical or certainty) diagnosis to treatment onset in cancer patients: the choice of diagnostic date strongly influences differences in therapeutic delay by tumor site and stage. J Clin Epidemiol. 2013;66(8): 928-939.